Biomedical Engineering Reference
In-Depth Information
[11] Barton JK, Hoying JB, Sullivan CJ. use of microbubbles as an optical coherence tomog-
raphy contrast agent.
Acad Radiol
2002;
9
(Suppl 1):S52-S55.
[12] van den Berg NS, van leeuwen FW, van der Poel HG. Fluorescence guidance in urologic
surgery.
Curr opin Urol
2012;
22
:109-120.
[13] liu DZ, Mathes DW, Zenn Mr, Neligan PC. The application of indocyanine green fluo-
rescence angiography in plastic surgery.
J Reconstr Microsurg
2011;
27
:355-364.
[14] Wagnieres GA, Star WM, Wilson BC.
In vivo
fluorescence spectroscopy and imaging for
oncological applications.
Photochem Photobiol
1998;
68
:603-632.
[15] Zhang Q, Iwakuma N, Sharma P, Moudgil BM, Wu C, McNeill J, Jiang H, Grobmyer Sr.
Gold nanoparticles as a contrast agent for
in vivo
tumor imaging with photoacoustic
tomography.
Nanotechnology
2009;
20
:395102.
[16] Ku G, Wang lV. Deeply penetrating photoacoustic tomography in biological tissues
enhanced with an optical contrast agent.
opt Lett
2005;
30
:507-509.
[17] Pilatou MC, Marani e, de Mul FF, Steenbergen W. Photoacoustic imaging of brain
perfusion on albino rats by using evans blue as contrast agent.
Arch Physiol Biochem
2003;
111
:389-397.
[18] Bloch S, lesage F, McIntosh l, Gandjbakhche A, liang K, Achilefu S. Whole-body
fluorescence lifetime imaging of a tumor-targeted near-infrared molecular probe in mice.
J Biomed opt
2005;
10
:054003.
[19] lee SB, Hassan M, Fisher r, Chertov o, Chernomordik V, Kramer-Marek G,
Gandjbakhche A, Capala J. Affibody molecules for
in vivo
characterization of Her2-
positive tumors by near-infrared imaging.
Clin Cancer Res
2008;
14
:3840-3849.
[20] Berezin MY, Guo K, Akers W, Northdurft re, Culver JP, Teng B, Vasalatiy o,
Barbacow K, Gandjbakhche A, Griffiths Gl, Achilefu S. Near-infrared fluorescence
lifetime ph-sensitive probes.
Biophys J
2011;
100
:2063-2072.
[21] Cui l, Zhong Y, Zhu W, Xu Y, Du Q, Wang X, Qian X, Xiao Y. A new prodrug-derived
ratiometric fluorescent probe for hypoxia: high selectivity of nitroreductase and imaging
in tumor cell.
org Lett
2011;
13
:928-931.
[22] Nakata e, Yukimachi Y, Kariyazono H, Im S, Abe C, uto Y, Maezawa H, Hashimoto T,
okamoto Y, Hori H. Design of a bioreductively-activated fluorescent pH probe for tumor
hypoxia imaging.
Bioorg Med Chem
2009;
17
:6952-6958.
[23] okuda K, okabe Y, Kadonosono T, ueno T, Youssif BG, Kizaka-Kondoh S, Nagasawa H.
2-nitroimidazole-tricarbocyanine conjugate as a near-infrared fluorescent probe for
in vivo
imaging of tumor hypoxia.
Bioconjug Chem
2012;
23
:324-329.
[24] Youssif BG, okuda K, Kadonosono T, Salem oI, Hayallah AA, Hussein MA,
Kizaka-Kondoh S, Nagasawa H. Development of a hypoxia-selective near-infrared
fluorescent probe for non-invasive tumor imaging.
Chem Pharm Bull (Tokyo)
2012;
60
:402-407.
[25] Kobayashi H, ogawa M, Alford r, Choyke Pl, urano Y. New strategies for fluorescent
probe design in medical diagnostic imaging.
Chem Rev
2010;
110
:2620-2640.
[26] Kosaka N, ogawa M, Sato N, Choyke Pl, Kobayashi H.
In vivo
real-time, multicolor,
quantum dot lymphatic imaging.
J Invest Dermatol
2009;
129
:2818-2822.
[27] Andersson-engels S, Johansson J, Svanberg S. Medical diagnostic system based on
simultaneous multispectral fluorescence imaging.
Appl opt
1994;
33
:8022-8029.
[28] lakowicz Jr.
Principles of Fluorescence Spectroscopy
. 2nd ed. New York: Kluwer
Academic/Plenum; 1999.
Search WWH ::
Custom Search